IMMUNOTHERAPEUTIC TARGETING OF SLC39A9 IN CDKN2A-LOW MELANOMA

$442,557FY2025Defense Health AgencyDOD

The Wistar Institute Of Anatomy And Biology

Investigators

View source on USAspending →

IMMUNOTHERAPEUTIC TARGETING OF SLC39A9 IN CDKN2A-LOW MELANOMA · GrantIndex